BackOncoCyte Overview

OncoCyte Other Income Expense Net

Other Income/Expense Net for 0KCC.L.

Quarterly Other Income/Expense

$6.04M
↑ 4619.53% YoY

As of Mar 31, 2026

Annual Other Income/Expense (TTM)

$6.82M
↑ 1751.9% YoY

Trailing 12 months ending Mar 31, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin